Candesartan Cilexetil in Haemodialysis Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.8, 2003-01, pp. : 545-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study

By Schulz Egbert G.

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 713-719

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil steady-state concentrations are approximately twice as high in haemodialysis recipients

Inpharma, Vol. 1, Iss. 1402, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil prevents AF in patients with heart failure

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil similar to enalapril for hypertensive patients with LVH

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil may prevent diabetes in patients with HF

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite